5 completed. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
Follow cavosonstat: new trials by email Literature Review of cavosonstat trials Research Report on cavosonstat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Cavosonstat (N91115) in Healthy Subjects (SNO-9) Cavosonstat, Placebo - Cystic Fibrosis | Phase 1 | Completed | Nivalis Therapeutics, Inc. | 32 | 2016-10-01 | 2017-01-31 |
| A Drug-Drug Interaction Study of N91115 +/- Rifampin in Healthy Adult Subjects N91115, Rifampin - Drug Interaction Potentiation | Phase 1 | Completed | Nivalis Therapeutics, Inc. | 15 | 2015-06-01 | 2016-11-07 |
| Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation N91115 - Cystic Fibrosis | Phase 1 | Completed | Nivalis Therapeutics, Inc. | 51 | 2015-02-01 | 2016-11-07 |
| PK Study of N91115 in Cystic Fibrosis Patients N91115 - Cystic Fibrosis | Phase 1 | Completed | Nivalis Therapeutics, Inc. | 6 | 2014-10-01 | 2016-11-07 |
| MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetic Effects of N91115 in Healthy Subjects N91115, Placebo, Placebo-Day 1 only - Healthy | Phase 1 | Completed | Nivalis Therapeutics, Inc. | 49 | 2014-02-01 | 2016-12-21 |
Cystic Fibrosis (3)
Nivalis Therapeutics, Inc. (5)
United States (5)
Christopher Galloway, MD (2) · Robert Williams, MD (1) · Scott Donaldson, MD (1) · Steven A Shoemaker, MD (1) · Steven Shoemaker, MD (1)